Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trial
Saad, Fred, Cella, David, Basch, Ethan, Hadaschik, Boris A, Mainwaring, Paul N, Oudard, Stéphane, Graff, Julie N, McQuarrie, Kelly, Li, Susan, Hudgens, Stacie, Lawson, Joe, Lopez-Gitlitz, Angela, Yu,Language:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(18)30456-X
Date:
September, 2018
File:
PDF, 1.13 MB
english, 2018